Alkermes
development plan seek early clinical evidence of activity synaptic and assessments are core components of the early clinical development plan and program decision making early clinical development plan objectives phase study planned initiation phase sad mad planned initiation identify differences in synaptic between healthy volunteers and patients with neurodegenerative diseases and inform indication selection determine relationship and in healthy volunteers determine effects on select phase basket studies in and neurodegenerative disorders confirm effect on of and function indications and for proof of concept studies sad single ascending dose mad multiple ascending dose pharmacodynamic maximum tolerated dose | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
126 of 144
Related slides by other companies
Larimar Therapeutics
Investor Presentation
November 2023
clinical development plan | Larimar Therapeutics
Equillium
Investor Presentation
November 2023
milestones | Equillium
Erasca
Investor Presentation
January 2024
clinical development plan generates multiple ways to win for patients | Erasca
BenevolentAI
Investor Presentation
October 2022
ben phase progressing phase double blind placebo controlled in patient two part clinical study day day day day active recruiting sites in the in a further sites under approval recruitment completion anticipated our intention is to to partner this asset with a pharmaceutical company that has a focus in dermatology for continued clinical development and if approved our intention is to out development and of ben following completion of this trial with key big and dermatology specialists as potential part | BenevolentAI
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io